Neuvivo Closes on Additional Funding Round for NP001 Development

Company Adds Bruce A. Kaufman to New Chief Financial Officer Role PALO ALTO, Calif., May 26, 2022 /PRNewswire/ -- Neuvivo, a late-clinical stage biopharmaceutical company developing a new ALS treatment, today announced that it has closed on an additional round of financing led by an...

Click to view original post